March 26, 2012
ACC: Biologic Wows for Lipid Lowering
A novel monoclonal antibody when added to statin therapy substantially cuts LDL cholesterol levels beyond reductions achieved with statin therapy alone, a phase II study found…Subcutaneous injection every two weeks dropped LDL by 40% to 72% more than placebo across the doses tested among patients uncontrolled on their background regimen of atorvastatin (Lipitor), James M. […]
Tags: James M. McKenney, lipids, National Clinical Research, Rick A. Nishimura